EU regulator recommends approval for ARS pharma's nasal spray alternative to EpiPen-March 2024-www.financetom.com

EU regulator recommends approval for ARS pharma's nasal spray alternative to EpiPen

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

EU regulator recommends approval for ARS pharma's nasal spray alternative to EpiPen

Jun 28, 2024 4:17 AM

June 28 (Reuters) - ARS Pharmaceuticals ( SPRY ) said on

Friday the European Medicines Agency (EMA) recommended the

approval of its needle-free emergency treatment for allergic

reactions.

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Open Text Up 5.5% After Hours as it Posts a Lower Fiscal Fourth-Quarter Profit But Tops Estimates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Open Text Up 5.5% After Hours as it Posts a Lower Fiscal Fourth-Quarter Profit But Tops Estimates

Aug 7, 2025

04:35 PM EDT, 08/07/2025 (MT Newswires) -- Open Text ( OTEX ) shares were last seen up 5.5% in after-hours Nasdaq trading as the company after-trade Thursday said its fiscal fourth-quarter profit and revenue fell slightly year-over-year. The company earned US$409.9 million, or US$0.97 per share, in the quarter ended June 30, down from US$413.5 million, or US$0.98, a year...

Lumen Technologies Insider Bought Shares Worth $501,782, According to a Recent SEC Filing

Aug 7, 2025

04:35 PM EDT, 08/07/2025 (MT Newswires) -- Kathleen E Johnson, Director, President & CEO, on August 05, 2025, executed a purchase for 135,870 shares in Lumen Technologies ( LUMN ) for $501,782. Following the Form 4 filing with the SEC, Johnson has control over a total of 11,895,309 common shares of the company, with 9,616,947 shares held directly and 2,278,362...

Gilead Sciences Q2 Adjusted Earnings Unchanged, Revenue Rises; Dividend Maintained

Aug 7, 2025

04:34 PM EDT, 08/07/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported fiscal Q2 adjusted earnings late Thursday of $2.01 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected $1.96. Revenue for the quarter ended June 30 was $7.08 billion, up from $6.95 billion a year earlier. Analysts surveyed by FactSet expected $6.98 billion. The...